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Logistic regression analysis revealed that smoking history, hyperten-
sion, epicardium existed signiﬁcant difference between the CAD
group and the non-CAD group (P<0.05). The thickness of the epicar-
dium and the sum of VF were increased gradually in the three groups
of CAD, and there were signiﬁcant differences between the three
groups (P<0.05). Compared with the non NAFLD group, the thickness
of liver fat, perirenal fat, pararenal fat and epicardium in NAFLD
group were signiﬁcantly increased (P<0.05). In the NAFLD group and
non NAFLD group, the thickness of the epicardium was associated
with CAD, suggesting predictive value for the diagnosis of CAD.
However, the cut-off value of CAD in NAFLD group was higher than
that of non NAFLD group. With the increase of Gensini value, the VF
of NAFLD group had no signiﬁcant increase (P>0.05). With the in-
crease of Gensini value, the epicardium thickness in the three groups
of CAD had a signiﬁcant increase (P<0.05), and the thickness of other
parts VF had no signiﬁcant change (P>0.05).
CONCLUSIONS Epicardium, hypertension, smoking are independent
risk factors for CAD. Epicardium thickness is associated with the de-
gree of coronary artery stenosis. The VF is easily accumulated in the
patients with NAFLD. The epicardium thickness has a predictive value
for the incidence and the severity of CAD in patients without NAFLD.
In patients with NAFLD, epicardium thickness has predictive value for
the incidence of CAD, but there is no predictive value for the severity
of CAD.GW26-e4800
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OBJECTIVES To investigate the association of resistin with propro-
tein convertase subtilisin-kexin type 9 (PCSK9) levels, another novel
regulator of atherosclerosis, in the condition of coronary artery dis-
ease (CAD).
METHODS We prospectively enrolled a total of 356 consecutive stable
CAD patients who were not treated with lipid-lowering drugs in the
present study. The baseline clinical characteristics were collected.
Plasma PCSK9 and resistin levels were determined by ELISA. The
relationship between plasma PCSK9 and resistin levels was
investigated.
RESULTS Overall, plasma resistin exhibited a positive nonparametric
correlation with PCSK9 levels (r¼0.123, p¼0.02). When the patients
were classiﬁed into groups based on body mass index (BMI), the
resistin correlated signiﬁcantly to the PCSK9 levels in patients with
BMI < 25 kg/m2 (r¼0.162, p¼0.026) but not in patients with BMI  25
kg/m2 (r¼0.087, p¼0.205). Multivariate regression analysis corrobo-
rated the relation between the PCSK9 and an elevated resistin level in
patients with BMI < 25 kg/m2 independently of traditional parameters
including age, sex, BMI, smoking, family history of CAD, systolic
blood pressure, glucose, low density lipoprotein cholesterol, white
blood cell, neutrophil to lymphocyte ratio, and high-sensitive C-
reactive protein.
CONCLUSIONS Plasma resistin was positively related to PCSK9 levels
in CAD patients with normal weight, suggesting that the circulating
resistin might represent a link with PCSK9 level variations in CAD
progression of normal body weight.GW26-e5470
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University, Changsha ChinaOBJECTIVES We aimed to explore the diagnostic value of circulating
miRNAs (miR-149, miR-208b, miR-378, miR-424, miR-499 and
miR-765) in AMI patients, and protective role of miR-208b or miR-378
or metoprolol during H/R injury in H9c2 cell with their underlying
mechanisms.
METHODS 205 AMI patients and 85 healthy subjects, twelve week-old
C57BL/6 mice AMI and H9c2 cells were included in this study. AMI
patients were diagnosed according to ESC/ACCF/AHA/WHF guide-
lines. Total RNA was isolated from plasma and cardiac cell with TRIzol
reagent. Circulating miRNAs levels were measured by quantitative
real-time polymerase chain reaction.
RESULTS We found that miR-208b, miR-499 and miR-765 levels
were signiﬁcantly up-regulated by 9.6 fold, 5.2 fold, and 5.1 fold
in AMI patients compared with healthy subjects (p<0.001). Plasma
miR-149, miR-378 and miR-424 levels were markedly down-
regulated by 5.5 fold, 4.9 fold and 5 fold in AMI patients compared
with controls (p<0.001). Plasma levels of these miRNAs were
returned towards normal at 96h after PCI (p<0.001). We also found
that plasma miR-208b, miR-499 and miR-765 levels were signiﬁ-
cantly elevated by 11.5 fold, 3.9 fold, and 4.7 fold, while miR-149,
miR-378 and miR-424 levels were noticeably decreased by 3.7 fold,
4.1 fold and 3.8 fold in Mice AMI compared with controls
(p<0.001). The ROC curves of plasma miR-208b, miR-499, miR-765,
miR-149, miR-378 and miR-424 represented a strong discrimina-
tion between AMI patients and healthy subjects, with an area
under curve (AUC) of 0.974, 0.971, 0.965, 0.963 0.969 and 0.973,
respectively.
Moreover, the expression of miR-208b was signiﬁcantly up-regu-
lated in hypoxic/reoxygenation (H/R) injury by 33.36 fold, whereas,
miR-378 was extensively down-regulated in H/R injury by 5.08 fold
compared with controls(p<0.01). Furthermore, inhibition of miR-208b
and over expression of miR-378 were dramatically decreased cell
injury and utmost increased cell survival through negative regulation
of NLK and TRAF6 in H/R injured cardiac cell. Moreover, H/R-induced
H9c2 cells treatment with metoprolol at 106 mM obviously decreased
cell apoptosis, caspase-3 activity, NADPH oxidase activity, LDH
release, and intracellular ROS production, and signiﬁcantly elevated
cell viability (p<0.001).
CONCLUSIONS Our ﬁndings suggested that miR-208b, miR-499,
miR-765, miR-149, miR-378, miR-424 may be used as a novel
and sensitive diagnostic biomarker for AMI patients. Inhibition of
miR-208b and overexpression of miR-378 were effectively protected
cardiomyocyte damage during H/R injury through their potential
targets NLK and TRAF6, represents a new therapeutic approach for
ischemic heart disease. Furthermore, metoprolol protected car-
diomyocytes damage against H/R injury by suppressing oxidative
stress.
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OBJECTIVES Coronary heart disease (CHD) is a leading cause of
morbidity and mortality in adults worldwide. It is gradually emerging
as a major public health problem in many developing countries
including Nepal. Consequences of CHD are that it often results in
depletion of the health related quality of life (HRQL) of patients. The
aim of this study was to assess the HRQL of CHD patients.
METHODS A descriptive cross sectional design was used to assess
HRQL of 254 CHD patients attending out-patient department of Sha-
hid Gangalal National Heart Centre (SGNHC), Bansbari, Kathmandu,
Nepal. Purposive sampling technique was used for data collection by
face to face interview technique using the MacNew Health - related
Quality of Life tool.
RESULTS The results of the study showed that mean  SD for
emotional domain was 3.87  1.01, for physical domain was 3.81 
0.88 and social domain was 3.82  0.88 and global score of HRQL was
3.83  0.87 on 7- point likert scale. As the different domains of HRQL
was signiﬁcantly correlated with each others. The descriptive statis-
tics of individual domain scores according to level of HRQL was found
to be greater number in below average group in each domain
including global HRQL score.
CONCLUSIONS The HRQL score of CHD patients attending a cardiac
centre are below average. Hence, Self Instructional Module (SIM) on
“Living well with CHD” should be developed to enhanced quality
of life.
